COMBINED USE OF ECTEINASCIDIN-743 AND PLATINUM ANTINEOPLASTIC COMPOUNDS
摘要
ET-743 can be used to mitigate resistance to and potentiate the cytotoxic effects of a platinum coordination complex anti-neoplastic agent in a human cancer patient.
申请公布号
CA2525887(A1)
申请公布日期
2004.12.09
申请号
CA20042525887
申请日期
2004.06.01
申请人
PHARMA MAR, S.A.U.
发明人
GARCIA MARTIN, MARGARITA;JIMENO, DONAQUE JOSE MARIA;SESSA, CRISTIANA;GIANNI, LUCA;D'INCALCI, MAURIZIO;GIAVAZZI, RAFAELLA;JUDSON, IAN
